These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 973959)

  • 81. Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor.
    Pickles H; Perucca E; Fish A; Richens A
    Clin Pharmacol Ther; 1981 Sep; 30(3):303-10. PubMed ID: 6115732
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man.
    Gugler R; Höbel W; Bodem G; Dengler HJ
    Clin Pharmacol Ther; 1975 Feb; 17(2):127-33. PubMed ID: 1122674
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.
    Aellig WH
    Br J Clin Pharmacol; 1982; 13(Suppl 2):187S-192S. PubMed ID: 6125169
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Modification by indomethacin of the blood pressure lowering effect of pindolol and propranolol in conscious rabbits.
    Durão V; Rico JM
    Eur J Pharmacol; 1977 Jun; 43(4):377-81. PubMed ID: 880982
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Beta-adrenoceptive responses in the unanaesthetized ovine foetus.
    Van Petten GR; Willes RF
    Br J Pharmacol; 1970 May; 38(3):572-82. PubMed ID: 5441411
    [TBL] [Abstract][Full Text] [Related]  

  • 86. l-Bunolol and propranolol: oral and intravenous beta-adrenoceptor blocking activity in rats compared to dogs and humans.
    Kaplan HR; Commarato MA; Lattime EC
    J Pharm Sci; 1978 Jan; 67(1):132-3. PubMed ID: 22739
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Assessment of beta blockade with propranolol.
    Hager WD; Pieniaszek HJ; Perrier D; Mayersohn M; Goldberger V
    Clin Pharmacol Ther; 1981 Sep; 30(3):283-90. PubMed ID: 6115730
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Role of beta adrenoceptors in the hypertrophic response to thyroxine.
    Eliades D; Weiss HR
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):58-65. PubMed ID: 2475716
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Measurement of partial agonist activity of pindolol.
    Carruthers SG; Twum-Barima Y
    Clin Pharmacol Ther; 1981 Nov; 30(5):581-6. PubMed ID: 7297017
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
    Wagner F; Jähnchen E; Trenk D
    Eur J Clin Pharmacol; 1989; 36(6):579-82. PubMed ID: 2570700
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cardiac dose-response relationships of oral and intravenous pindolol.
    Carruthers SG
    Br J Clin Pharmacol; 1982; 13(Suppl 2):193S-198S. PubMed ID: 7104142
    [No Abstract]   [Full Text] [Related]  

  • 92. Plasma concentrations and the time-course of beta blockade due to propranolol.
    McDevitt DG; Shand DG
    Clin Pharmacol Ther; 1975 Dec; 18(6):708-13. PubMed ID: 1169
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Duration of biological activity of pindolol in uremics (author's transl)].
    Herb HM; Heinze V
    Klin Wochenschr; 1979 Aug; 57(16):851-4. PubMed ID: 502352
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Local and systemic effects of pindolol eye drops.
    Mekki QA; Penhall R; Edgar DF; Stewart-Jones JH; Turner P
    Br J Clin Pharmacol; 1983 Jan; 15(1):112-3. PubMed ID: 6849733
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The effect of the beta-adrenoceptor antagonist pindolol on exercise performance.
    Dhatariya RC; Blowers AJ
    Br J Clin Pharmacol; 1982 May; 13(5):723-7. PubMed ID: 7082540
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oral and intravenous propranolol during exercise.
    Sutton JR; Hughson RL; McDonald R; Powles P; Jones NL; Fitzgerald JD
    Clin Pharmacol Ther; 1977 Jun; 21(6):700-5. PubMed ID: 862308
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of beta-blockers on sodium and potassium content of human erythrocytes.
    Nathan I; Dvilansky A; Gross M; Korczyn AD
    Arch Int Physiol Biochim; 1979 Dec; 87(5):935-41. PubMed ID: 94824
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect on heart rate over 24 hours of pindolol administered for 14 days.
    Kantelip JP; Trolese JF; Cromarias PG; Duchêne-Marullaz P
    Eur J Clin Pharmacol; 1984; 27(5):535-8. PubMed ID: 6542864
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effects of d- and l-propranolol on the acute hypotension induced by pindolol in conscious spontaneously hypertensive rats (SHR).
    Matsunaga K; Ueda M
    Jpn J Pharmacol; 1982 Jun; 32(3):577-9. PubMed ID: 7109354
    [No Abstract]   [Full Text] [Related]  

  • 100. Simultaneous modeling of bopindolol kinetics and dynamics.
    Platzer R; Galeazzi RL; Niederberger W; Rosenthaler J
    Clin Pharmacol Ther; 1984 Jul; 36(1):5-13. PubMed ID: 6329585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.